ＭＺＴ（株）ゼブラフィッシュ創薬研究所

最近の記事

2019/02/19: Clinical Implication of Zebrafish-Based Developmental Toxicology

2019/02/14: Frontiers in Systems Pharmacogy

2019/02/05: Patient-Derived Cancer Xenograft-Driven Zebrafish-Based Drug Discovery and Precision Medicine

2019/01/01: 謹賀新年２０１９次世代ゼブラフィッシュ創薬とプレシジョンメディシン

2018/12/03: 腫瘍血管新生のプレシジョンメディシン

2018/11/20: 第４回ゼブラフィッシュ・メダカ創薬研究会基調講演報告

2018/11/07: phenomic screening by Dravet syndrome zebrafish model

2018/10/24: 次世代ゼブラフィッシュ創薬とプレシジョンメディシン

2018/09/11: ゼブラフィッシュ創薬とプレシジョンメディシン

2018/08/31: ゼブラフィッシュ創薬とプレシジョン医療

一覧に戻る

2010/10/03

In vivo high content screening system using zebrafish models of various human diseases.

We constructed metabolic syndrome and human cancer transplant models of zebrafish for high content and throughput in vivo screening systems. These systems are suitable for drug discovery and functional food screening. Furthermore, we conduct the transcriptome analysis to reveal the mechanism of the therapeutic compounds.

BioJapan 2010-World Business Forum
Renaissance of Bioindustry / Ride a Right wave of open innovation
September 29th (Wed.) - October 1st (Fri), 2010 10:00 - 17:00

ＭＺＴ（株）ゼブラフィッシュ創薬研究所

最近の記事

In vivo high content screening system using zebrafish models of various human diseases.

関連リンク